Live Breaking News & Updates on மரிஜுவானா ஆராய்ச்சி நாடகம்
Stay updated with breaking news from மரிஜுவானா ஆராய்ச்சி நாடகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
What to Expect from the Cannabis Industry in 2021 2020 was a hell of a year for the cannabis industry. Cannabis was deemed an essential business during a global pandemic. It proved to be a bipartisan issue, as several red states voted to legalize recreational and medical cannabis. Plus the House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act) and the Medical Marijuana Research Act (MMJ Research Act), both now pending before the Senate. As we move into 2021, what can we expect from the industry next? Pending Cannabis Legislations Passage of the MORE Act The MORE Act’s passage would remove marijuana from the schedules of controlled substances under the Controlled Substances Act (CSA). The MORE Act demonstrated that there is enough bipartisan support to pass in the House of Representatives, and it could likely pass the Senate in 2021. However, the timeframe for the passage of this act heavily lies on the Se ....
With legal weed coming to New Jersey, U.S. must open doors for cannabis research Monday, 11 January 2021 There’s an ancient botanical that millions of Americans take for epilepsy, cancer pain, Parkinson’s disease, post-traumatic stress disorder, multiple sclerosis and other serious and debilitating conditions. The drug is cannabis. But American researchers who want to study cannabis are thwarted at every turn. Federal law still classifies cannabis as a Schedule 1 drug, a list that includes highly dangerous and addictive drugs such as heroin. The government says cannabis has no accepted medical use and a high potential for abuse. Even cocaine is not a Schedule 1 drug. ....
National House Passes Medical Marijuana Research Bill. The House last Wednesday approved the Medical Marijuana Research Act (HR 3797) on a voice vote, demonstrating strong support from Democrats and Republicans alike. The measure would remove limits on marijuana research by amending the Controlled Substances Act and would direct the Justice Department and the Department of Health and Human Services to establish a program to provide licenses to more marijuana growers and manufacturers. Licensed researchers could then use that marijuana in research approved by the FDA. Senate Approves Medical Marijuana Research Bill. With a favorable vote Tuesday night, the Senate has passed the Cannabidiol and Marihuana Research Expansion Act (S.2302). It would ease the application process for marijuana researchers and would prod the Food and Drug Administration (FDA) to develop medicines derived from marijuana. The House passed a separate marijuana research bill last week. The passage of ....
California Panel Recommends Regulators Relax Rules for Struggling Cannabis Businesses The Cannabis Advisory Committee recommended changes to help licensed businesses compete with the illicit market. Recommended changes were included in the committee’s annual report, and include eliminating a $5,000 limit on the amount of cannabis that can be transported by delivery vans to make it easier for small businesses to sell different products, as well as pave the way for food and beverages to eventually be served in cannabis lounges, the news outlet reported. Other recommendations include expanding the activities allowed under the state’s microbusiness licenses to include the processing of cannabis products, as well as allowing the licensees to conduct sales at licensed events, according to the ....
Richard DeLisi, American s longest-serving nonviolent marijuana offender, is now a free man. (family photo) Medical Marijuana House Passes Medical Marijuana Research Bill. The House on Wednesday approved the Medical Marijuana Research Act (HR 3797) on a voice vote, demonstrating strong support from Democrats and Republicans alike. The measure would remove limits on marijuana research by amending the Controlled Substances Act and would direct the Justice Department and the Department of Health and Human Services to establish a program to provide licenses to more marijuana growers and manufacturers. Licensed researchers could then use that marijuana in research approved by the FDA. The bill is an orphan, though; there is no equivalent measure in the Senate. ....